257 related articles for article (PubMed ID: 2236458)
21. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
[TBL] [Abstract][Full Text] [Related]
22. Pharmacotherapy of obsessive-compulsive disorder.
Klein DF
Encephale; 1990; 16 Spec No():331-4. PubMed ID: 2209491
[TBL] [Abstract][Full Text] [Related]
23. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.
Mavissakalian M; Jones B; Olson S; Perel JM
Psychopharmacol Bull; 1990; 26(1):119-22. PubMed ID: 2371366
[TBL] [Abstract][Full Text] [Related]
24. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
Simeon JG; Thatte S; Wiggins D
Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
[TBL] [Abstract][Full Text] [Related]
25. Worldwide use of clomipramine.
Trimble MR
J Clin Psychiatry; 1990 Aug; 51 Suppl():51-4; discussion 55-8. PubMed ID: 2199435
[TBL] [Abstract][Full Text] [Related]
26. Clinical features associated with treatment response in obsessive-compulsive disorder.
Shavitt RG; Belotto C; Curi M; Hounie AG; Rosário-Campos MC; Diniz JB; Ferrão YA; Pato MT; Miguel EC
Compr Psychiatry; 2006; 47(4):276-81. PubMed ID: 16769302
[TBL] [Abstract][Full Text] [Related]
27. Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.
Fallon BA; Liebowitz MR; Campeas R; Schneier FR; Marshall R; Davies S; Goetz D; Klein DF
Arch Gen Psychiatry; 1998 Oct; 55(10):918-24. PubMed ID: 9783563
[TBL] [Abstract][Full Text] [Related]
28. Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder.
Fallon BA; Campeas R; Schneier FR; Hollander E; Feerick J; Hatterer J; Goetz D; Davies S; Liebowitz MR
J Neuropsychiatry Clin Neurosci; 1992; 4(1):70-5. PubMed ID: 1627966
[TBL] [Abstract][Full Text] [Related]
29. Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.
Arch Gen Psychiatry; 1991 Aug; 48(8):730-8. PubMed ID: 1883256
[TBL] [Abstract][Full Text] [Related]
30. Clomipramine for obsessive-compulsive disorder.
Feinberg M
Am Fam Physician; 1991 May; 43(5):1735-8. PubMed ID: 2021107
[TBL] [Abstract][Full Text] [Related]
31. Clomipramine (Anafranil) and behaviour therapy in obsessive-compulsive and phobic disorders.
Amin MM; Ban TA; Pecknold JC; Klingner A
J Int Med Res; 1977; 5 Suppl 5():33-7. PubMed ID: 340305
[TBL] [Abstract][Full Text] [Related]
32. Treatment of obsessive-compulsive neurosis with clomipramine (Anafranil).
Ananth J
J Int Med Res; 1977; 5 Suppl 5():38-41. PubMed ID: 598604
[TBL] [Abstract][Full Text] [Related]
33. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
[TBL] [Abstract][Full Text] [Related]
34. Double-blind controlled study in phobias and obsessions.
Karabanow O
J Int Med Res; 1977; 5 Suppl 5():42-8. PubMed ID: 340306
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy of obsessive-compulsive disorder.
Jermain DM; Crismon ML
Pharmacotherapy; 1990; 10(3):175-98. PubMed ID: 2196535
[TBL] [Abstract][Full Text] [Related]
36. [A control study of clomipramine and amitriptyline for treating obsessive-compulsive disorder].
Zhao JP
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Apr; 24(2):68-70, 123. PubMed ID: 1860383
[TBL] [Abstract][Full Text] [Related]
37. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
Milanfranchi A; Ravagli S; Lensi P; Marazziti D; Cassano GB
Int Clin Psychopharmacol; 1997 May; 12(3):131-6. PubMed ID: 9248868
[TBL] [Abstract][Full Text] [Related]
38. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
Zohar J; Judge R
Br J Psychiatry; 1996 Oct; 169(4):468-74. PubMed ID: 8894198
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic studies in obsessional patients.
Luscombe DK; Marks IM
J Int Med Res; 1977; 5 Suppl 5():91-6. PubMed ID: 598610
[TBL] [Abstract][Full Text] [Related]
40. Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
Mundo E; Maina G; Uslenghi C
Int Clin Psychopharmacol; 2000 Mar; 15(2):69-76. PubMed ID: 10759337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
